Lab Rats series: A Bengaluru startup’s bid to drug the undruggable
Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to build a preclinical pipeline targeting rare diseases and previously undruggable proteins.
Lean: Not rated
Fact-focusedCountry: IndiaFunding: CorporateOwner: Independent
Coverage breakdown
Funding
Corporate
Countries
India
Media ownership
Independent
Avg reliability-
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 34 (Weakly supported)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: Not rated
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 0
Amplification: 0